Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

Abstract Background The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) has recommended that isocitrate dehydrogenase 1 and 2 wildtype (IDH1/2wt) diffuse lower-grade gliomas (LGGs) World Health Organization (WHO) grade II or III that present with (i) a tel...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2020-04, Vol.22 (4), p.515-523
Hauptverfasser:	Tesileanu, C Mircea S, Dirven, Linda, Wijnenga, Maarten M J, Koekkoek, Johan A F, Vincent, Arnaud J P E, Dubbink, Hendrikus J, Atmodimedjo, Peggy N, Kros, Johan M, van Duinen, Sjoerd G, Smits, Marion, Taphoorn, Martin J B, French, Pim J, van den Bent, Martin J
Format:	Artikel
Sprache:	eng
Schlagworte:	Astrocytoma - genetics Brain Neoplasms - genetics Clinical Investigations Glioblastoma - genetics Humans Isocitrate Dehydrogenase - genetics Mutation Prognosis Retrospective Studies World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!